{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:28:31Z","timestamp":1780590511065,"version":"3.54.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:00:00Z","timestamp":1468022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12016-016-8569-0","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:20:19Z","timestamp":1468023619000},"page":"54-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome\u2014A Retrospective Analysis and a Review of Additional Treatment in Pregnancy"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3077-108X","authenticated-orcid":false,"given":"Karoline","family":"Mayer-Pickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Cervar-Zivkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"8569_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"8569_CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.autrev.2011.04.030","volume":"10","author":"C Galarza-Maldonado","year":"2011","unstructured":"Galarza-Maldonado C, Kourilovitch MR, P\u00e9rez-Fern\u00e1ndez OM et al (2011) Obstetric antiphospholipid syndrome. Autoimmun Rev 10:669\u2013673","journal-title":"Autoimmun Rev"},{"key":"8569_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","volume":"48-49","author":"RA Asherson","year":"2014","unstructured":"Asherson RA, Cervera R (2014) The antiphospholipid syndrome: multiple faces beyond the classical presentation. J Autoimmun 48-49:20\u201325","journal-title":"J Autoimmun"},{"key":"8569_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","volume":"48\u201349","author":"JA G\u00f3mez-Puerta","year":"2014","unstructured":"G\u00f3mez-Puerta JA, Cervera R (2014) Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun 48\u201349:20\u201325","journal-title":"J Autoimmun"},{"key":"8569_CR5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","volume":"12","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Cacoub P (2013) Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmun Rev 12:752\u2013757","journal-title":"Autoimmun Rev"},{"key":"8569_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","volume":"13","author":"D Erkan","year":"2014","unstructured":"Erkan D, Aguiar CL, Andrade D et al (2014) 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13:685\u2013696","journal-title":"Autoimmun Rev"},{"key":"8569_CR7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/0961203312458839","volume":"21","author":"A Carrera-Mar\u00edn","year":"2012","unstructured":"Carrera-Mar\u00edn A, Romay-Penabad Z, Papalardo E et al (2012) C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus 21:1497\u20131505","journal-title":"Lupus"},{"key":"8569_CR8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0035-1556725","volume":"41","author":"PG Groot De","year":"2015","unstructured":"De Groot PG, Urbanus RT (2015) Antiphospholipid syndrome\u2014not a noninflammatory disease. Semin Thromb Hemost 41:607\u2013614","journal-title":"Semin Thromb Hemost"},{"key":"8569_CR9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2003","unstructured":"Girardi G, Berman J, Redecha P et al (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112:1644\u20131654","journal-title":"J Clin Invest"},{"key":"8569_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L et al (2002) Complement C3 activation is required antiphospholipid antibody induced fetal loss. J Exp Med 195:211\u2013220","journal-title":"J Exp Med"},{"key":"8569_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","volume":"28","author":"I Cavazzana","year":"2007","unstructured":"Cavazzana I, Manuela N, Irene C et al (2007) Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 28:160\u2013164","journal-title":"J Autoimmun"},{"key":"8569_CR12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0961203312438116","volume":"21","author":"PL Meroni","year":"2012","unstructured":"Meroni PL, Raschi E, Grossi C et al (2012) Obstetric and vascular APS: same autoantibodies but different disease? Lupus 21:108\u2013710","journal-title":"Lupus"},{"key":"8569_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e3181c97809","volume":"65","author":"J Alijotas-Reig","year":"2010","unstructured":"Alijotas-Reig J, Vilardell-Tarr\u00e8s M (2010) Is obstetric antiphospholipid syndrome a primary nonthrombotic proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 65:39\u201345","journal-title":"Obstet Gynecol Surv"},{"key":"8569_CR14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203310395054","volume":"20","author":"W Branch","year":"2011","unstructured":"Branch W, Obstetric Task Force (2011) Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies.13th April 2010. Lupus 20:158\u2013164","journal-title":"Lupus"},{"key":"8569_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0961203309361484","volume":"19","author":"RA Levy","year":"2010","unstructured":"Levy RA, Jes\u00fas GR, Jes\u00fas NR (2010) Obstetric antiphospholipid syndrome: still a challenge. Lupus 19:457\u2013459","journal-title":"Lupus"},{"key":"8569_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1157\/13077146","volume":"125","author":"J Alijotas-Reig","year":"2005","unstructured":"Alijotas-Reig J (2005) Towards the comprehension of heterogeneity of clinical manifestations related to antiphospholipid antibodies. Med Clin (Barc) 125:187\u2013189","journal-title":"Med Clin (Barc)"},{"key":"8569_CR17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","volume":"13","author":"GR Jesus De","year":"2014","unstructured":"De Jesus GR, Agmon-Levin N, Andrade CA et al (2014) International Congress on Antiphospholipid Antibodies task force report on obstetric antiphospholipid syndrome. Autoimmun Rev 13:795\u2013813","journal-title":"Autoimmun Rev"},{"key":"8569_CR18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.autrev.2014.05.004","volume":"13","author":"S D\u2019Ippolito","year":"2014","unstructured":"D\u2019Ippolito S, Meroni PL, Koike T, Veglia M, Scambia G, Di Simone N (2014) Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder. Autoimmun Rev 13:901\u2013908","journal-title":"Autoimmun Rev"},{"key":"8569_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/AOG.0b013e31820a61f9","volume":"117","author":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Obstetrics","year":"2011","unstructured":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins\u2014Obstetrics (2011) ACOG Practice Bulletin No. 118: antiphospholipid syndrome. Obstet Gynecol 117:192\u2013199","journal-title":"Obstet Gynecol"},{"key":"8569_CR20","doi-asserted-by":"crossref","unstructured":"Tranquilli AL et al (2013) The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens 3:44\u201347","DOI":"10.1016\/j.preghy.2012.11.001"},{"key":"8569_CR21","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31"},{"key":"8569_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","volume":"9","author":"EA Clark","year":"2007","unstructured":"Clark EA, Silver RM, Branch DW (2007) Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 9:219\u2013225","journal-title":"Curr Rheumatol Rep"},{"key":"8569_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"8569_CR24","first-page":"541","volume":"73","author":"DW Branch","year":"1989","unstructured":"Branch DW, Andres R, Digre KB, Rote NS, Scott JR (1989) The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 73:541\u2013545","journal-title":"Obstet Gynecol"},{"key":"8569_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9378(91)90222-D","volume":"165","author":"J Milliez","year":"1991","unstructured":"Milliez J, Lelong F, Bayani N et al (1991) The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 165:51\u201356","journal-title":"Am J Obstet Gynecol"},{"key":"8569_CR26","first-page":"105","volume":"85","author":"J Moddley","year":"1995","unstructured":"Moddley J, Bhoola V, Duursma J, Pudifin D, Byrne S, Kenoyer DG (1995) The association of antiphospholipid antibodies with severe early-onset preeclampsia. S Afr Med J 85:105\u2013107","journal-title":"S Afr Med J"},{"key":"8569_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","volume":"14","author":"J Alijotas-Reig","year":"2015","unstructured":"Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, EUROAPS Study Group Collaborators et al (2015) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev 14:387\u2013395","journal-title":"Autoimmun Rev"},{"key":"8569_CR28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","volume":"19","author":"K Bramham","year":"2010","unstructured":"Bramham K, Hunt BJ, Germain S et al (2010) Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 19:58\u201364","journal-title":"Lupus"},{"key":"8569_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","volume":"66","author":"D Raymond","year":"2011","unstructured":"Raymond D, Peterson E (2011) A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 66:497\u2013506","journal-title":"Obstet Gynecol Surv"},{"key":"8569_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.b2255","volume":"338","author":"S Hern\u00e1ndez-D\u00edaz","year":"2009","unstructured":"Hern\u00e1ndez-D\u00edaz S, Toh S, Cnattingius S (2009) Risk of preeclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338:1\u20135","journal-title":"BMJ"},{"key":"8569_CR31","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","volume":"109","author":"AK Wikstrom","year":"2007","unstructured":"Wikstrom AK, Larson A, Eriksson UJ et al (2007) Placental growth factor and soluble fms-like tyrosine kinase-1 in early onset and late-onset preeclampsia. Obstet Gynecol 109:1368\u20131374","journal-title":"Obstet Gynecol"},{"key":"8569_CR32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","volume":"49","author":"H Stepan","year":"2007","unstructured":"Stepan H, Unversucht A, Wessel N et al (2007) Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 49:818\u2013824","journal-title":"Hypertension"},{"key":"8569_CR33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00439-006-0259-1","volume":"120","author":"CB Oudejans","year":"2007","unstructured":"Oudejans CB, van Dijk M, Oosterkamp M et al (2007) Genetics of preeclampsia: paradigm shifts. Hum Genet 120:607\u2013612","journal-title":"Hum Genet"},{"key":"8569_CR34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51:970\u2013975","journal-title":"Hypertension"},{"key":"8569_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajog.2013.09.010","volume":"210","author":"DB Nelson","year":"2014","unstructured":"Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ (2014) Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol 210:66\u201367","journal-title":"Am J Obstet Gynecol"},{"key":"8569_CR36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2350\/13-09-1378-OA.1","volume":"17","author":"MW Stark","year":"2014","unstructured":"Stark MW, Clark L, Craver RD (2014) Histologic differences in placentas of preeclamptic\/eclamptic gestations by birthweight, placental weight, and time of onset. Pediatr Dev Pathol 17:181\u2013189","journal-title":"Pediatr Dev Pathol"},{"key":"8569_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0143-4004(98)90100-X","volume":"19","author":"CM Salafia","year":"1998","unstructured":"Salafia CM, Pezzulo JC, Ghidini A et al (1998) Clinical correlations of patterns of placental pathology in preterm preeclampsia. Placenta 19:67\u201372","journal-title":"Placenta"},{"key":"8569_CR38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.placenta.2004.11.007","volume":"27","author":"D Goswami","year":"2006","unstructured":"Goswami D, Tannetta DA, Magee LA et al (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset preeclampsia, but not normotensive intrauterine growth restriction. Placenta 27:56\u201361","journal-title":"Placenta"},{"issue":"5","key":"8569_CR39","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","volume":"60","author":"A Buurma","year":"2012","unstructured":"Buurma A, Cohen D, Veraar K et al (2012) Preeclampsia is characterized by placental complement dysregulation. Hypertension 60(5):1332\u20131337","journal-title":"Hypertension"},{"key":"8569_CR40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon AC, Cornelius DC, Amaral LM et al (2016) The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond) 130:409\u2013419","journal-title":"Clin Sci (Lond)"},{"key":"8569_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","volume":"14","author":"M \u00d8stensen","year":"2015","unstructured":"\u00d8stensen M, Andreoli L, Brucato A et al (2015) State of the art: Reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 14:376\u2013386","journal-title":"Autoimmun Rev"},{"key":"8569_CR42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","volume":"14","author":"CA Viall","year":"2015","unstructured":"Viall CA, Chamley LW (2015) Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature. Autoimmun Rev 14:446\u2013471","journal-title":"Autoimmun Rev"},{"key":"8569_CR43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-2007-994176","volume":"14","author":"C Salafia","year":"1997","unstructured":"Salafia C, Cowchock F (1997) Placental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 14:435\u2013441","journal-title":"Am J Perinatol"},{"key":"8569_CR44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","volume":"25","author":"JT Horn Van","year":"2004","unstructured":"Van Horn JT, Craven C, Ward K, Branch DW, Silver RM (2004) Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25:642\u2013648","journal-title":"Placenta"},{"key":"8569_CR45","first-page":"1333","volume":"101","author":"DW Branch","year":"2003","unstructured":"Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Am J Obstet Gynecol 101:1333\u20131344","journal-title":"Am J Obstet Gynecol"},{"key":"8569_CR46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033\u20131044","journal-title":"N Engl J Med"},{"key":"8569_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/107602960300900209","volume":"9","author":"L Heilmann","year":"2003","unstructured":"Heilmann L, von Tempelhoff GF, Pollow K (2003) Antiphospholipid syndrome in obstetrics. Clin Appl Thrombosis Hemostasis 9:143\u2013150","journal-title":"Clin Appl Thrombosis Hemostasis"},{"issue":"8","key":"8569_CR48","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0029-1145261","volume":"34","author":"L Heilmann","year":"2008","unstructured":"Heilmann L, Schorch M, Hahn T et al (2008) Pregnancy outcome in women with antiphospholipid antibodies: report of a retrospective study. Semin Thromb Hemost 34(8):794\u2013802","journal-title":"Semin Thromb Hemost"},{"key":"8569_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-009-8146-x","volume":"38","author":"M Blank","year":"2010","unstructured":"Blank M, Shoenfeld Y (2010) Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clin Rev Allergy Immunol 38:141\u2013147","journal-title":"Clin Rev Allergy Immunol"},{"key":"8569_CR50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.autrev.2011.10.006","volume":"11","author":"C Galarza-Maldonado","year":"2012","unstructured":"Galarza-Maldonado C, Kourilovitch MR, Perez-Fernandez OM et al (2012) Obstetric antiphospholipid syndrome. Autoimmun Rev 11:288\u2013295","journal-title":"Autoimmun Rev"},{"key":"8569_CR51","first-page":"205","volume":"6","author":"RA Levy","year":"2015","unstructured":"Levy RA, dos Santos FC, de Jesus GR, de Jesus NR (2015) Antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: diagnostic concepts. Front Immunol 6:205","journal-title":"Front Immunol"},{"key":"8569_CR52","first-page":"372","volume":"83","author":"RM Silver","year":"1994","unstructured":"Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW (1994) Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 83:372\u2013377","journal-title":"Obstet Gynecol"},{"key":"8569_CR53","first-page":"614","volume":"80","author":"DW Branch","year":"1992","unstructured":"Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80:614\u2013620","journal-title":"Obstet Gynecol"},{"key":"8569_CR54","first-page":"131","volume":"14","author":"F Lima","year":"1996","unstructured":"Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR (1996) A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14:131\u2013136","journal-title":"Clin Exp Rheumatol"},{"key":"8569_CR55","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203312444172","volume":"21","author":"S Carolis De","year":"2012","unstructured":"De Carolis S, Botta A, Santucci S et al (2012) Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus 21:776\u2013778","journal-title":"Lupus"},{"key":"8569_CR56","doi-asserted-by":"crossref","first-page":"A299","DOI":"10.1016\/j.autrev.2009.11.013","volume":"9","author":"M Biggioggero","year":"2010","unstructured":"Biggioggero M, Meroni PL (2010) The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 9:A299\u2013A304","journal-title":"Autoimmun Rev"},{"key":"8569_CR57","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","volume":"50","author":"A Ruffatti","year":"2011","unstructured":"Ruffatti A, Tonello M, Visentin MS et al (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 50:1684\u20131689","journal-title":"Rheumatology (Oxford)"},{"key":"8569_CR58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.jhh.1000495","volume":"11","author":"N Sawhney","year":"1997","unstructured":"Sawhney N, Patel MK, Schachter M, Hughes AD (1997) Inhibition of proliferation by heparin and expression of p53 in cultured human vascular smooth muscle cells. J Hum Hypertens 11:611\u2013614","journal-title":"J Hum Hypertens"},{"key":"8569_CR59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0026-0495(98)90279-7","volume":"47","author":"M Kohno","year":"1998","unstructured":"Kohno M, Yokokawa K, Yasunari K et al (1998) Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism 47:1065\u20131069","journal-title":"Metabolism"},{"key":"8569_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0008-6363(98)00004-2","volume":"38","author":"RJ Dilley","year":"1998","unstructured":"Dilley RJ, Nataatmadja MI (1998) Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats. Cardiovasc Res 38:247\u2013255","journal-title":"Cardiovasc Res"},{"key":"8569_CR61","first-page":"135","volume":"99","author":"M Empson","year":"2002","unstructured":"Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99:135\u2013144","journal-title":"Obstet Gynecol"},{"key":"8569_CR62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0961203312465782","volume":"22","author":"J Alijotas-Reig","year":"2013","unstructured":"Alijotas-Reig J (2013) Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. Lupus 22:6\u201317","journal-title":"Lupus"},{"key":"8569_CR63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.autrev.2011.04.030","volume":"10","author":"T Scoble","year":"2011","unstructured":"Scoble T, Wijetilleka S, Khamashta MA (2011) Management of refractory anti-phospholipid syndrome. Autoimmun Rev 10:669\u2013673","journal-title":"Autoimmun Rev"},{"key":"8569_CR64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autrev.2010.08.004","volume":"10","author":"L Andreoli","year":"2010","unstructured":"Andreoli L, Bazzani C, Taraborelli M et al (2010) Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 10:51\u201354","journal-title":"Autoimmun Rev"},{"key":"8569_CR65","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","volume":"117","author":"K Bramham","year":"2011","unstructured":"Bramham K, Thomas M, Nelson-Piercy C et al (2011) First trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 117:6948\u20136951","journal-title":"Blood"},{"issue":"337","key":"8569_CR66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","volume":"17","author":"CA Laskin","year":"1997","unstructured":"Laskin CA, Bombardier C, Hannah ME et al (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 17(337):148\u2013153","journal-title":"N Engl J Med"},{"key":"8569_CR67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","volume":"68","author":"R Kaiser","year":"2009","unstructured":"Kaiser R, Cleveland CM, Criswell LA (2009) Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multiethnic cohort. Ann Rheum Dis 68:238\u2013241","journal-title":"Ann Rheum Dis"},{"issue":"115","key":"8569_CR68","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","volume":"18","author":"JH Rand","year":"2010","unstructured":"Rand JH, Wu XX, Quinn AS et al (2010) Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood 18(115):2292\u20132299","journal-title":"Blood"},{"key":"8569_CR69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/aji.12184","volume":"71","author":"CR Albert","year":"2014","unstructured":"Albert CR, Schlesinger WJ, Viall CA et al (2014) Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. Am J Reprod Immunol 71:154\u2013164","journal-title":"Am J Reprod Immunol"},{"key":"8569_CR70","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jth.12570","volume":"12","author":"T Marchetti","year":"2014","unstructured":"Marchetti T, Ruffatti A, Wuillemin C, de Moerloose P, Cohen M (2014) Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost 12:910\u2013920","journal-title":"J Thromb Haemost"},{"issue":"376","key":"8569_CR71","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","volume":"30","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 30(376):1498\u20131509","journal-title":"Lancet"},{"key":"8569_CR72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Lazzaroni MG, Kuzenko A et al (2015) The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study. Autoimmun Rev 14:498\u2013502","journal-title":"Autoimmun Rev"},{"key":"8569_CR73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.autrev.2015.04.010","volume":"14","author":"S Carolis De","year":"2015","unstructured":"De Carolis S, Botta A, Salvi S et al (2015) Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? Autoimmun Rev 14:760\u2013762","journal-title":"Autoimmun Rev"},{"key":"8569_CR74","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","volume":"14","author":"C Belizna","year":"2015","unstructured":"Belizna C (2015) Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. Autoimmun Rev 14:358\u201362","journal-title":"Autoimmun Rev"},{"key":"8569_CR75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autrev.2014.08.040","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Costedoat-Chalumeau N, Masseau A et al (2015) Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev 14:23\u201329","journal-title":"Autoimmun Rev"},{"issue":"273","key":"8569_CR76","first-page":"e1","volume":"214","author":"S Sciascia","year":"2016","unstructured":"Sciascia S, Hunt BJ, Talavera-Garcia E, Lliso G, Khamashta MA, Cuadrado MJ (2016) The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol 214(273):e1\u2013e8","journal-title":"Am J Obstet Gynecol"},{"issue":"115","key":"8569_CR77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/th15-06-0491","volume":"27","author":"S Sciascia","year":"2016","unstructured":"Sciascia S, Branch DW, Levy RA et al (2016) The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. Thromb Haemost 27(115):285\u2013290","journal-title":"Thromb Haemost"},{"key":"8569_CR78","first-page":"1","volume":"3","author":"A Al Marzooqi","year":"2016","unstructured":"Al Marzooqi A, Leone A, Al Saleh J, Khamashta M (2016) Current status and future prospects for the treatment of antiphospholipid syndrome. Expert Rev Clin Immunol 3:1\u20139","journal-title":"Expert Rev Clin Immunol"},{"key":"8569_CR79","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW (2012) Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 367:2015\u20132025","journal-title":"N Engl J Med"},{"key":"8569_CR80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.autrev.2015.03.005","volume":"14","author":"GM Guidelli","year":"2015","unstructured":"Guidelli GM, Tenti S, Pascarelli NA et al (2015) Granulomatosis with polyangitis and intravenous immunoglobulins: a case series and review of the literature. Autoimmun Rev 14:659\u2013664","journal-title":"Autoimmun Rev"},{"key":"8569_CR81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0897.1998.tb00394.x","volume":"40","author":"G Sher","year":"1998","unstructured":"Sher G, Matzner W, Feinman M et al (1998) The selective use of heparin\/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 40:74\u201382","journal-title":"Am J Reprod Immunol"},{"key":"8569_CR82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2015.11.009","volume":"15","author":"S Tenti","year":"2016","unstructured":"Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A (2016) Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature. Autoimmun Rev 15:226\u2013235","journal-title":"Autoimmun Rev"},{"key":"8569_CR83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"DW Branch","year":"2000","unstructured":"Branch DW, Peaceman AM, Druzin M et al (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182:122\u2013127","journal-title":"Am J Obstet Gynecol"},{"key":"8569_CR84","first-page":"139","volume":"51","author":"FR Danesh","year":"2003","unstructured":"Danesh FR, Anel RL, Zeng L, Lomasney J, Sahai A, Kanwar YS (2003) Immunomodulatory effects of HMG-CoA reductase inhibitors. Arch Immunol Ther Exp (Warsz) 51:139\u2013148","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"72","key":"8569_CR85","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11632010-000000000-00000","volume":"16","author":"E Lecarpentier","year":"2012","unstructured":"Lecarpentier E, Morel O, Fournier T, Elefant E, Chavatte-Palmer P, Tsatsaris V (2012) Statins and pregnancy: between supposed risks and theoretical benefits. Drugs 16(72):773\u2013788","journal-title":"Drugs"},{"key":"8569_CR86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/GCO.0000000000000026","volume":"25","author":"S Morton","year":"2013","unstructured":"Morton S, Thangaratinam S (2013) Statins in pregnancy. Curr Opin Obstet Gynecol 25:433\u2013440","journal-title":"Curr Opin Obstet Gynecol"},{"key":"8569_CR87","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C (2012) Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm 18:1519\u20131530","journal-title":"Curr Pharm"},{"issue":"16","key":"8569_CR88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","volume":"20","author":"FC Brownfoot","year":"2016","unstructured":"Brownfoot FC, Tong S, Hannan NJ, Hastie R, Cannon P, Kaitu\u2019u-Lino TJ (2016) Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. BMC Pregnancy Childbirth 20(16):117","journal-title":"BMC Pregnancy Childbirth"},{"key":"8569_CR89","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","volume":"214","author":"MM Costantine","year":"2016","unstructured":"Costantine MM, Cleary K, Hebert MF et al (2016) Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol 214:720.e1\u2013720.e17","journal-title":"Am J Obstet Gynecol"},{"key":"8569_CR90","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1161\/HYPERTENSIONAHA.114.03115","volume":"63","author":"E Lefkou","year":"2014","unstructured":"Lefkou E, Mamopoulos A, Fragakis N et al (2014) Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin. Hypertension 63:e118\u2013e119","journal-title":"Hypertension"},{"key":"8569_CR91","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2006.11.002","volume":"6","author":"A Ruffatti","year":"2007","unstructured":"Ruffatti A, Marson P, Pengo V et al (2007) Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 6:196\u2013202","journal-title":"Autoimmun Rev"},{"issue":"115","key":"8569_CR92","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2016.03.004","volume":"29","author":"A Ruffatti","year":"2016","unstructured":"Ruffatti A, Favaro M, Hoxha A et al (2016) Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study. J Reprod Immunol 29(115):14\u201319","journal-title":"J Reprod Immunol"},{"key":"8569_CR93","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.transci.2015.11.006","volume":"53","author":"A Ruffatti","year":"2015","unstructured":"Ruffatti A, Favaro M, Brucato A et al (2015) Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. Transfus Apher Sci 53:269\u2013278","journal-title":"Transfus Apher Sci"},{"key":"8569_CR94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jca.21229","volume":"27","author":"A Bontadi","year":"2012","unstructured":"Bontadi A, Ruffatti A, Marson P et al (2012) Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J Clin Apher 27:200\u2013204","journal-title":"J Clin Apher"},{"issue":"3","key":"8569_CR95","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/ard.51.3.399","volume":"51","author":"S Kobayashi","year":"1992","unstructured":"Kobayashi S, Tamura N, Tsuda H, Mokuno C, Hashimoto H, Hirose S (1992) Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. Ann Rheum Dis 51(3):399\u2013401","journal-title":"Ann Rheum Dis"},{"key":"8569_CR96","first-page":"55","volume":"16","author":"I Nakanishi","year":"1998","unstructured":"Nakanishi I, Fujita T, Shinohara K et al (1998) Treatment with immunoadsorbent plasmapheresis in a pregnant woman with antiphospholipid syndrome (in Japanese). J Osaka Soc Dialysis Therapy 16:55\u201358","journal-title":"J Osaka Soc Dialysis Therapy"},{"key":"8569_CR97","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0897.1999.tb00443.x","volume":"41","author":"Y Nakamura","year":"1999","unstructured":"Nakamura Y, Yoshida K, Itoh S et al (1999) Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies. Am J Reprod Immunol 41:307\u2013311","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"8569_CR98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1744-9987.2009.00671.x","volume":"13","author":"M Bortolati","year":"2009","unstructured":"Bortolati M, Marson P, Chiarelli S et al (2009) Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome. Ther Apher Dial 13(2):157\u2013160","journal-title":"Ther Apher Dial"},{"key":"8569_CR99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2007.05.045","volume":"99","author":"DO El-Haieg","year":"2007","unstructured":"El-Haieg DO, Zanati MF, El-Foual FM (2007) Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. Int J Gynaecol Obstet 99:236\u2013241","journal-title":"Int J Gynaecol Obstet"},{"key":"8569_CR100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(87)92584-0","volume":"31","author":"G Frampton","year":"1987","unstructured":"Frampton G, Cameron JS, Thom M, Jones S, Raftery M (1987) Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone. Lancet 31:1023\u20131024","journal-title":"Lancet"},{"key":"8569_CR101","first-page":"136","volume":"68","author":"ML Schwartz","year":"1986","unstructured":"Schwartz ML (1986) Possible role for exchange plasmapheresis with fresh frozen plasma for maternal indications in selected cases of preeclampsia and eclampsia. Obstet Gynecol 68:136\u2013139","journal-title":"Obstet Gynecol"},{"key":"8569_CR102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jca.2920090302","volume":"9","author":"JN Martin","year":"1994","unstructured":"Martin JN, Perry KG, Roberts WE, Norman PF, Files JC, Blake PG, Morrison JC, Wiser WL (1994) Plasma exchange for preeclampsia: II. Unsuccessful antepartum utilization for severe preeclampsia with or without HELLP syndrome. J Clin Apher 9:155\u2013161","journal-title":"J Clin Apher"},{"key":"8569_CR103","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1479-828X.1980.tb00773.x","volume":"20","author":"AJ d\u2019Apice","year":"1980","unstructured":"d\u2019Apice AJ, Reti LL, Pepperell RJ, Fairley KF, Kincaid-Smith P (1980) Treatment of severe pre-eclampsia by plasma exchange. Aust N Z J Obstet Gynaecol 20:231\u2013235","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"8569_CR104","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-009-0010-8","volume":"11","author":"A Tincani","year":"2009","unstructured":"Tincani A, Rebaioli CB, Andreoli L, Lojacono A, Motta M (2009) Neonatal effects of maternal antiphospholipid syndrome. Curr Rheumatol Rep 11:70\u201376","journal-title":"Curr Rheumatol Rep"},{"key":"8569_CR105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","volume":"72","author":"A Mekinian","year":"2013","unstructured":"Mekinian A, Lachassinne E, Nicaise-Roland P et al (2013) European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 72:217\u2013222","journal-title":"Ann Rheum Dis"},{"key":"8569_CR106","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1542\/peds.2008-1216","volume":"123","author":"M Delobel-Ayoub","year":"2009","unstructured":"Delobel-Ayoub M, Arnaud C, White-Koning M, EPIPAGE Study Group et al (2009) Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics 123:1485\u20131492","journal-title":"Pediatrics"},{"key":"8569_CR107","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0961203313501402","volume":"23","author":"C Nalli","year":"2014","unstructured":"Nalli C, Iodice A, Andreoli L et al (2014) The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Lupus 23:507\u2013517","journal-title":"Lupus"},{"key":"8569_CR108","doi-asserted-by":"crossref","first-page":"J197","DOI":"10.1016\/j.jaut.2011.11.010","volume":"38","author":"L Andreoli","year":"2012","unstructured":"Andreoli L, Fredi M, Nalli C et al (2012) Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 38:J197\u2013J208","journal-title":"J Autoimmun"},{"key":"8569_CR109","doi-asserted-by":"crossref","first-page":"A520","DOI":"10.1016\/j.autrev.2011.12.002","volume":"11","author":"G Carvalheiras","year":"2012","unstructured":"Carvalheiras G, Faria R, Braga J, Vasconcelos C (2012) Fetal outcome in autoimmune diseases. Autoimmun Rev 11:A520\u2013A530","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-016-8569-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8569-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8569-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8569-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:09:03Z","timestamp":1568142543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-016-8569-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["8569"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8569-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]}}}